PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medicine, Oregon Health & Science University, Portland, Oregon, USA friedmam@ohsu.edu.\', \'Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham Department of Medicine, Birmingham, Alabama, USA.\', \'Medicine, Oregon Health & Science University, Portland, Oregon, USA.\', \'School of Public Health, Oregon Health & Science University, Portland, Oregon, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/annrheumdis-2021-221244
?:doi
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 34493491
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of disease-modifying antirheumatic drugs on vaccine immunogenicity in patients with inflammatory rheumatic and musculoskeletal diseases.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all